Meera J. Desai - 01 Oct 2021 Form 4 Insider Report for Adamis Pharmaceuticals Corp

Role
Director
Signature
/s/ David C. Benedicto, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
06 Oct 2021, 17:03:35 UTC
Next filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMP Stock Appreciation Right Award $0 +50,000 $0.000000 50,000 01 Oct 2021 Common Stock 50,000 $1.01 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Stock Appreciation Right is the economic equivalent of one share of ADMP common stock and can only be settled in cash.
F2 The Stock Appreciation Right ("SAR") will vest with respect to 1/6 of the shares subject to the SAR on the six-month anniversary of the date of grant, and thereafter with respect to 1/36 of the shares on each monthly anniversary of the date of grant with all remaining unvested shares subject to the SAR vesting on the thirty-sixth (36th) monthly anniversary of the date of grant.